Clinical trials for Cancer in United States

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Study ID: NCT04792463

Sponsor

Mohamed Abdel-Rahman

Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

Study ID: NCT04975139

Sponsor

Washington University School of Medicine

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Study ID: NCT05496686

Sponsor

Modulation Therapeutics, Inc.

A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor

Study ID: NCT05288439

Sponsor

Memorial Sloan Kettering Cancer Center

A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium

Study ID: NCT05837039

Sponsor

M.D. Anderson Cancer Center

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Study ID: NCT04049539

Sponsor

Ohio State University Comprehensive Cancer Center

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Study ID: NCT05714839

Sponsor

GlaxoSmithKline

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Study ID: NCT06158139

Sponsor

UNC Lineberger Comprehensive Cancer Center

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Study ID: NCT06027086

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Study of Stored Tumor Samples in Young Patients With Brain Tumors

Study ID: NCT00897286

Sponsor

St. Jude Children's Research Hospital